|
Market Closed -
Other stock markets
|
After hours 01:17:06 am | |||
| 57.42 EUR | -0.28% |
|
57.15 | -0.47% |
| 17/07 | AKZO NOBEL NV : Bernstein remains Neutral | ZD |
| 14/07 | AKZO NOBEL NV : Bernstein reiterates its Neutral rating | ZD |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 958.7Cr | 1.08TCr | 1.07TCr | 1.07TCr | 1.02TCr | |||||
Total Revenues | 958.7Cr | 1.08TCr | 1.07TCr | 1.07TCr | 1.02TCr | |||||
Cost of Goods Sold, Total | 573.2Cr | 692.3Cr | 643.4Cr | 637.4Cr | 610.9Cr | |||||
Gross Profit | 385.5Cr | 392.3Cr | 423.4Cr | 433.7Cr | 404.9Cr | |||||
Selling General & Admin Expenses, Total | 256.1Cr | 293.9Cr | 296.2Cr | 309.1Cr | 296.9Cr | |||||
R&D Expenses | 23Cr | 26Cr | 27Cr | 30Cr | 27Cr | |||||
Other Operating Expenses | -2.5Cr | - | -6Cr | 60L | -70L | |||||
Other Operating Expenses, Total | 276.6Cr | 319.7Cr | 317.2Cr | 339.3Cr | 323.6Cr | |||||
Operating Income | 108.9Cr | 73Cr | 106.2Cr | 94Cr | 81Cr | |||||
Interest Expense, Total | -7.4Cr | -11Cr | -19Cr | -19Cr | -21Cr | |||||
Interest And Investment Income | 1.2Cr | 3.6Cr | 6.9Cr | 6.1Cr | 4.9Cr | |||||
Net Interest Expenses | -6.2Cr | -7Cr | -12Cr | -13Cr | -16Cr | |||||
Income (Loss) On Equity Invest. | 2.6Cr | 1.8Cr | 2.7Cr | 2.3Cr | 3.3Cr | |||||
Currency Exchange Gains (Loss) | - | -8.5Cr | -13Cr | -4.7Cr | -4.9Cr | |||||
Other Non Operating Income (Expenses) | -1.8Cr | 1.3Cr | -70L | 3.2Cr | 60L | |||||
EBT, Excl. Unusual Items | 103.5Cr | 60Cr | 83Cr | 82Cr | 64Cr | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | 66Cr | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | 7Cr | - | - | - | -27Cr | |||||
Other Unusual Items | - | - | -4.6Cr | 1.5Cr | -2.6Cr | |||||
EBT, Incl. Unusual Items | 110.5Cr | 60Cr | 78Cr | 84Cr | 100Cr | |||||
Income Tax Expense | 25Cr | 21Cr | 30Cr | 25Cr | 33Cr | |||||
Earnings From Continuing Operations | 86Cr | 39Cr | 49Cr | 59Cr | 67Cr | |||||
Earnings Of Discontinued Operations | 60L | -1Cr | -50L | - | -10L | |||||
Net Income to Company | 86Cr | 38Cr | 48Cr | 59Cr | 67Cr | |||||
Minority Interest | -3.6Cr | -2.6Cr | -4.1Cr | -5Cr | -3.6Cr | |||||
Net Income - (IS) | 83Cr | 35Cr | 44Cr | 54Cr | 64Cr | |||||
Net Income to Common Incl Extra Items | 83Cr | 35Cr | 44Cr | 54Cr | 64Cr | |||||
Net Income to Common Excl. Extra Items | 82Cr | 36Cr | 45Cr | 54Cr | 64Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.48 | 2.01 | 2.59 | 3.17 | 3.71 | |||||
Basic EPS - Continuing Operations | 4.45 | 2.07 | 2.62 | 3.17 | 3.72 | |||||
Basic Weighted Average Shares Outstanding | 18Cr | 17Cr | 17Cr | 17Cr | 17Cr | |||||
Net EPS - Diluted | 4.46 | 2 | 2.58 | 3.16 | 3.69 | |||||
Diluted EPS - Continuing Operations | 4.43 | 2.06 | 2.61 | 3.16 | 3.7 | |||||
Diluted Weighted Average Shares Outstanding | 19Cr | 18Cr | 17Cr | 17Cr | 17Cr | |||||
Normalized Basic EPS | 3.3 | 2 | 2.8 | 2.72 | 2.13 | |||||
Normalized Diluted EPS | 3.29 | 2 | 2.79 | 2.71 | 2.12 | |||||
Dividend Per Share | 1.98 | 1.98 | 1.98 | 1.98 | 1.98 | |||||
Payout Ratio | 43.91 | 107.67 | 83.26 | 62.36 | 53.39 | |||||
American Depositary Receipts Ratio (ADR) | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | |||||
Supplemental Items | ||||||||||
EBITDA | 134.6Cr | 100Cr | 132Cr | 121.5Cr | 108.8Cr | |||||
EBITA | 115.9Cr | 81Cr | 114.2Cr | 102.2Cr | 89Cr | |||||
EBIT | 108.9Cr | 73Cr | 106.2Cr | 94Cr | 81Cr | |||||
EBITDAR | 136Cr | 101.3Cr | 134.1Cr | 123.6Cr | 112.6Cr | |||||
Effective Tax Rate - (Ratio) | 22.26 | 35.55 | 37.76 | 29.36 | 32.67 | |||||
Total Current Taxes | 17Cr | 22Cr | 30Cr | 20Cr | 32Cr | |||||
Total Deferred Taxes | 7.7Cr | -80L | -90L | 4.9Cr | 20L | |||||
Normalized Net Income | 61Cr | 35Cr | 48Cr | 46Cr | 36Cr | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 60L | 60L | 70L | 90L | 1Cr | |||||
Non-Cash Pension Expense | -3.5Cr | -1.8Cr | -3.2Cr | -2.6Cr | -2.2Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 199.2Cr | 230.8Cr | 234.7Cr | 246.3Cr | 235.2Cr | |||||
General and Administrative Expenses | 58Cr | 65Cr | 65Cr | 66Cr | 65Cr | |||||
Research And Development Expense From Footnotes | 23Cr | 26Cr | 27Cr | 30Cr | 27Cr | |||||
Net Rental Expense, Total | 1.4Cr | 1.7Cr | 2.1Cr | 2.1Cr | 3.8Cr | |||||
Imputed Operating Lease Interest Expense | 25.74L | 30.59L | 56.69L | 58.4L | 1.25Cr | |||||
Imputed Operating Lease Depreciation | 1.14Cr | 1.39Cr | 1.53Cr | 1.52Cr | 2.55Cr | |||||
Stock-Based Comp., Other (Total) | 1.8Cr | 1.6Cr | 1.8Cr | 2.3Cr | 2.4Cr | |||||
Total Stock-Based Compensation | 1.8Cr | 1.6Cr | 1.8Cr | 2.3Cr | 2.4Cr |
- Stock Market
- Stocks
- AKZA Stock
- Financials Akzo Nobel N.V.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















